Rab Pharma

UsesWhat is Cibinqo used for?
Cibinqo (abrocitinib) is commonly used to treat a disorder that causes inflammation and irritation of your skin called atopic dermatitis, which is the most common type of eczema. 
Learn more about Cibinqo for Atopic Dermatitis.
Cibinqo may also be used for other conditions as determined by your healthcare provider.

Crisaborole ointment, sold under the brand name Eucrisa, is a topical anti-inflammatory medication approved for treating mild-to-moderate eczema (atopic dermatitis) in adults and children. It works by inhibiting phosphodiesterase 4 (PDE4), a natural substance that causes inflammation and itchiness. The ointment is applied to affected areas twice daily and may cause side effects like burning, stinging, or itching at the application site.  
How it works
PDE4 inhibitor: 
Crisaborole blocks the action of PDE4, an enzyme involved in the body's inflammatory response. 
Reduces inflammation and itch: 
By inhibiting PDE4, crisaborole decreases the production of pro-inflammatory cytokines (natural substances that trigger inflammation), helping to reduce redness, swelling, and the intense itching associated with eczema. 
Interrupts the itch-scratch cycle: 
By alleviating the itch, crisaborole can help break the cycle of scratching and further skin damage that is common in eczema. 
How to use it 
Application: Apply a thin layer of the ointment to the affected skin area, as directed by your doctor.
Frequency: Apply twice daily.
Hygiene: Wash your hands before and after application.
Common side effects
Burning or stinging at the application site is the most common side effect. 
Other side effects can include itching, redness, or worsening of the eczema.